Physician profile
Johnathan Mccabe
NPI 1760422489
$1,120.00
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $14.96 · 2021: $94.27 · 2022: $159.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $174.93 | 2019-2022 | |
| Abiomed | $139.95 | 2019 | |
| Amgen INC. | $127.17 | 2019-2020 | |
| Terumo Medical Corporation | $115.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $98.98 | 2019 | |
| Biotronik INC. | $94.27 | 2021 | |
| Janssen Pharmaceuticals, INC | $68.83 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $66.03 | 2019 | |
| Novartis Pharmaceuticals Corporation | $47.72 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $42.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $41.15 | 2019 | |
| Abbott Laboratories | $34.27 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.71 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $24.51 | 2019 | |
| Preventice Services, LLC | $16.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathan Mccabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.